Fort Pitt Capital Group, LLC Abbott Laboratories Transaction History

Fort Pitt Capital Group, LLC

$3.27 Billion
Q2 2024

A detailed history of Fort Pitt Capital Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fort Pitt Capital Group, LLC holds 786,780 shares of ABT stock, worth $89.6 Million. This represents 2.5% of its overall portfolio holdings.

Number of Shares

786,780

Previous 743,326 5.85%

Holding current value

$89.6 Million

Previous $84.5 Million 3.23%

% of portfolio

2.5%

Previous 2.68%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$100.73 - $112.44 $4.38 Million - $4.89 Million	43,454 Added 5.85%	786,780 $81.8 Million
Q1 2024 Apr 11, 2024	BUY	$109.52 - $120.96 $1.3 Million - $1.44 Million	11,902 Added 1.63%	743,326 $84.5 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $234,223 - $286,708	2,597 Added 0.36%	731,424 $80.5 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $1.27 Million - $1.53 Million	13,335 Added 1.86%	728,827 $70.6 Million
Q2 2023 Jul 28, 2023	BUY	$100.78 - $112.29 $611,835 - $681,712	6,071 Added 0.86%	715,492 $78 Million
Q1 2023 May 16, 2023	BUY	$96.86 - $114.01 $716,860 - $843,788	7,401 Added 1.05%	709,421 $71.8 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $567,413 - $665,662	5,969 Added 0.86%	702,020 $77.1 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $618,006 - $715,535	-6,387 Reduced 0.91%	696,051 $67.4 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $698,362 - $844,097	6,842 Added 0.98%	702,438 $76.3 Million
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $2.29 Million - $2.79 Million	20,060 Added 2.97%	695,596 $82.3 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $2.13 Million - $2.6 Million	18,415 Added 2.8%	675,536 $95.1 Million
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $206,371 - $228,307	1,769 Added 0.27%	657,121 $77.6 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $1.65 Million - $1.94 Million	15,607 Added 2.44%	655,352 $76 Million
Q1 2021 Apr 16, 2021	SELL	$108.84 - $128.23 $750,887 - $884,658	-6,899 Reduced 1.07%	639,745 $76.7 Million
Q4 2020 Feb 24, 2021	BUY	$105.0 - $114.42 $67.8 Million - $73.9 Million	645,998 Added 99999.69%	646,644 $70.8 Million
Q4 2020 Feb 23, 2021	SELL	$105.0 - $114.42 $68.3 Million - $74.5 Million	-650,844 Reduced 99.9%	646 $70.8 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $1.43 Million - $1.74 Million	-15,621 Reduced 2.34%	651,490 $70.9 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $140,199 - $179,438	-1,831 Reduced 0.27%	667,111 $61 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $3.76 Million - $5.49 Million	59,799 Added 9.82%	668,942 $52.8 Million
Q4 2019 Feb 18, 2020	SELL	$78.51 - $87.4 $105,988 - $117,990	-1,350 Reduced 0.22%	609,143 $52.9 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $186,758 - $202,504	2,282 Added 0.38%	610,493 $51.1 Million
Q2 2019 Aug 09, 2019	BUY	$72.88 - $85.0 $11.4 Million - $13.3 Million	156,378 Added 34.61%	608,211 $51.2 Million
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $854,966 - $1.03 Million	-12,911 Reduced 2.78%	451,833 $36.1 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $195,106 - $221,027	2,976 Added 0.64%	464,744 $33.6 Million
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $241,415 - $291,239	-3,970 Reduced 0.85%	461,768 $33.9 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $119,169 - $131,527	-2,070 Reduced 0.44%	465,738 $28.4 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $113,777 - $128,639	-2,022 Reduced 0.43%	467,808 $28 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $133,287 - $142,698	-2,483 Reduced 0.53%	469,830 $26.8 Million
Q3 2017 Oct 26, 2017	SELL	$48.06 - $53.64 $26,096 - $29,126	-543 Reduced 0.11%	472,313 $25.2 Million
Q2 2017 Aug 17, 2017	BUY	N/A	472,856	472,856 $23 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Pitt Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Pitt Capital Group, LLC with notifications on news.

Account

Fort Pitt Capital Group, LLC Abbott Laboratories Transaction History